SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Ipsen S.A. (IPSEY) trades at a trailing P/E of 38.4, forward P/E of 16.1. Trailing earnings yield is 2.60%, forward earnings yield 6.21%. PEG 0.10 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (40/100, Partial) — mixed signals — some valuation metrics are favorable while others are stretched.
- Forward P/E 16.1 (down from trailing 38.4) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 0.10 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 2.60% — below bond yields — investors are paying a premium for expected growth rather than current earnings. Forward yield improves to 6.21% as earnings recover.
Overall SharesGrow Score: 61/100 with 2/7 criteria passed.
SharesGrow 7-Criteria Score
~
VALUE
40/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — IPSEY
Valuation Multiples
P/E (TTM)38.4
Forward P/E16.1
PEG Ratio0.10
Forward PEG0.12
P/B Ratio0.00
P/S Ratio4.65
EV/EBITDA0.0
Per Share Data
EPS (TTM)$1.28
Forward EPS (Est.)$3.05
Book Value / Share$0.00
Revenue / Share$10.56
FCF / Share$0.00
Yields & Fair Value
Earnings Yield2.60%
Forward Earnings Yield6.21%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$0.17 |
$1.67B |
$225.9M |
13.5% |
| 2017 |
$0.21 |
$2.01B |
$272.3M |
13.5% |
| 2018 |
$0.29 |
$2.35B |
$389.5M |
16.6% |
| 2019 |
$-0.04 |
$2.69B |
$-58.3M |
-2.2% |
| 2020 |
$0.41 |
$2.69B |
$548M |
20.4% |
| 2021 |
$0.49 |
$3B |
$646.6M |
21.6% |
| 2022 |
$0.49 |
$3.16B |
$648.6M |
20.5% |
| 2023 |
$1.85 |
$3.31B |
$644.4M |
19.5% |
| 2024 |
$0.26 |
$3.57B |
$345.9M |
9.7% |
| 2025 |
$1.28 |
$3.53B |
$426.96M |
12.1% |
